Kisspeptin-10

Human clinical Hormonal Health In 1 protocol 3 sources

Kisspeptin-10 is a potent neuropeptide that acts as an upstream regulator of the hypothalamic-pituitary-gonadal (HPG) axis. Research shows it stimulates the release of gonadotropin-releasing hormone (GnRH), subsequently increasing luteinizing hormone (LH), follicle-stimulating hormone (FSH), and testosterone levels. It is heavily studied for its potential in treating infertility, hypogonadism, and reproductive disorders.

01Dosing reference

Amount

100-300 mcg per dose

Frequency

1-3 times per week (pulsatile mimicry)

Cycle

4-8 weeks on, followed by a break to prevent desensitization

Reference figures, not a recommendationThese values reflect amounts described in the literature and vendor documentation this database indexes. Use the reconstitution calculator to convert them into syringe units.

02Mechanism of action

KISS1R Activation

Kisspeptin-10 binds to the KISS1 receptor (GPR54) on GnRH neurons in the hypothalamus.

GnRH Release

This binding triggers the pulsatile release of gonadotropin-releasing hormone (GnRH) into the portal circulation.

Gonadotropin Secretion

GnRH stimulates the anterior pituitary gland to secrete LH and FSH, which then signal the gonads to produce sex hormones like testosterone and estrogen.

03Human evidence

Intravenous and subcutaneous administration of Kisspeptin-10 significantly increases LH and testosterone levels in healthy men.

Phase 1/2 clinical trials evaluating acute hormonal responses; limited by short duration of action.

Kisspeptin can safely trigger oocyte maturation in women undergoing in vitro fertilization (IVF) with a lower risk of ovarian hyperstimulation syndrome (OHSS).

Clinical studies in women seeking fertility treatments, showing efficacy as an alternative trigger to hCG.

04Preclinical evidence

Kisspeptin administration restores reproductive function and initiates puberty in animal models with KISS1R mutations.

Rodent models demonstrating the critical role of kisspeptin in the onset of puberty.

Continuous high-dose administration leads to desensitization of the KISS1 receptor, suppressing the HPG axis.

Animal studies highlighting the importance of pulsatile versus continuous exposure.

05What is known vs. unknown

Reasonably established

Acts as a master regulator of human reproduction and puberty.
Stimulates the body's natural production of LH, FSH, and testosterone.
Has a very short half-life, requiring specific dosing strategies to mimic natural pulsatile release.
Studied as a safer alternative to hCG for triggering ovulation in IVF.

Unknowns & limits

The optimal dosing protocol to prevent receptor downregulation and maintain sustained testosterone elevation is still under investigation.
Long-term safety and efficacy data for chronic use in hypogonadism are lacking.

06Safety & regulatory context

Regulatory statusIn clinical settings, Kisspeptin-10 is generally well-tolerated with mild side effects such as flushing or injection site reactions. However, continuous or overly frequent administration can cause paradoxical suppression of the reproductive axis due to receptor desensitization. It is not FDA-approved for the treatment of hypogonadism or as a standalone fertility drug, and remains an investigational compound. Regulatory status restricts its use to research and clinical trials.

07Compared with hCG (Human Chorionic Gonadotropin)

Kisspeptin-10 vs. hCG (Human Chorionic Gonadotropin)

Key difference

hCG acts directly on the testes (mimicking LH) to produce testosterone, whereas Kisspeptin-10 acts upstream at the hypothalamus to stimulate the entire HPG axis.

When researchers discuss each

hCG is discussed as an established, direct stimulator of gonadal function, while Kisspeptin-10 is explored for restoring the natural pulsatile rhythm of the entire reproductive axis.

08Appears in protocols

⚖️ Hormonal Optimization Protocol

100 mcg/dayDaily

09Glossary

Hypothalamic-Pituitary-Gonadal (HPG) Axis

The system of endocrine glands that regulates reproductive function and hormone production.

GnRH (Gonadotropin-Releasing Hormone)

A hormone produced in the hypothalamus that triggers the pituitary gland to release LH and FSH.

Receptor Desensitization

A process where receptors become less responsive to a hormone or drug after continuous exposure.

10Knowledge check

Q1Where does Kisspeptin-10 primarily act to stimulate the reproductive axis?

Q2What is a potential consequence of continuous, high-dose administration of Kisspeptin-10?

Q3Which limitation in the human clinical evidence most directly restricts conclusions about Kisspeptin-10's long-term effectiveness for sustaining testosterone increases?

Q4According to the dossier, how does Kisspeptin-10's mechanism differ from hCG when researchers compare their effects on the reproductive axis?

Q5Which statement best reflects the dossier's safety and regulatory status of Kisspeptin-10?

11Sources

More in Hormonal Health

See all

Gonadorelin

Hormonal Health

FDA-approved context

Gonadorelin is a synthetic version of gonadotropin-releasing hormone (GnRH). It stimulates the anterior pituitary gland to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn stimulate the gonads to produce testosterone and sperm in males, and estrogen and eggs in females.

100-200 mcg per dose

hCG (Human Chorionic Gonadotropin)

Hormonal Health

FDA-approved context

hCG is a hormone naturally produced during pregnancy that mimics luteinizing hormone (LH) in the body. In research and clinical settings, it is widely used to stimulate testosterone production, preserve fertility, and treat hypogonadism in men, as well as to induce ovulation in women.

250-500 IU

HMG (Human Menopausal Gonadotropin)

Hormonal Health

FDA-approved context

Human Menopausal Gonadotropin (HMG) is a medication containing both follicle-stimulating hormone (FSH) and luteinizing hormone (LH), typically extracted from the urine of postmenopausal women. It is widely used in reproductive medicine to stimulate ovulation in women and spermatogenesis in men, often as part of assisted reproductive technologies (ART) or hypogonadism treatments.

75-150 IU per injection

Research and educational use onlyNothing on this site is medical advice, a prescription, or a recommendation for human use. Compounds documented here are research chemicals. Consult a qualified clinician before making any health decision.